It is reported that PTGS2 (also known as COX-2) was involved in podocyte injury and various renal pathological processes such as renal interstitial fibrosis, showing a potential therapeutic target against lupus nephritis-induced nephropathy [74, 75]. Here, PTGS2 is linked to kidney disorder.